Ventilator-associated pneumonia in neonatal patients: An update

Neonatology

Volumn 105, Issue 2, 2014, Pages 98-107

  Cernada, María ^a,b   Brugada, María ^a,b   Golombek, Sergio ^c   Vento, Máximo ^a,b  

^a HEALTH RESEARCH INSTITUTE LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Infections; Intubation; Mechanical ventilation; Newborn; Pneumonia

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROBIOTIC AGENT; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; BACTERIUM ISOLATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG USE; ESCHERICHIA COLI; EXTUBATION; FALSE POSITIVE RESULT; HAND WASHING; HUMAN; IMMUNE SYSTEM; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; INVASIVE PROCEDURE; KLEBSIELLA PNEUMONIAE; LEUKOCYTE ACTIVATION; LUNG LAVAGE; MECHANICAL VENTILATOR; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NEONATOLOGIST; NEWBORN; NON INVASIVE PROCEDURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TRACHEAL ASPIRATION PROCEDURE; TRACHEOBRONCHIAL TOILET; TREATMENT RESPONSE; UREAPLASMA UREALYTICUM; VENTILATOR ASSOCIATED PNEUMONIA; WASTE MANAGEMENT; LABORATORY DIAGNOSIS; METHODOLOGY; MICROBIOLOGY;

BIOLOGICAL MARKERS; HUMANS; INCIDENCE; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; SPECIMEN HANDLING;

EID: 84902846729     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000355539     Document Type: Review

References (73)

1. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants am J Obstet Gynecol 2007; 196: 147.e141-e148
2. Markestad T, Kaaresen PI, Ronnestad A, et al. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005; 115: 1289-1298
3. Vento M, Cheung PY, Aguar M. The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neonatology 2009; 95: 286-298
4. Miller JD, Carlo WA. Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol 2008; 35: 273-281, x-xi
5. Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 192-199
6. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 am J Infect Control 2004; 32: 470-485
7. Centers for Disease Control and Prevention: Criteria for defining nosocomial pneumonia. www.cdc.gov/ncidod/hip/NNIS/members/penumonia/Final/PneuCriteriaFinal.pdf (accessed January 17, 2009)
8. Baltimore RS. The difficulty of diagnosing ventilator-associated pneumonia. Pediatrics 2003; 112: 1420-1421
9. Morris AC, Kefala K, Simpson AJ, et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009; 64: 516-522
10. Cernada M, Aguar M, Brugada M, et al. Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatr Crit Care Med 2013; 14: 55-61
11. Tripathi SH, Malik GK, Jain A, Kohli N. Study of ventilator associated pneumonia in neonatal intensive care unit: characteristics, risk factors and outcome. Internet J Med Update 2010; 5: 12-19
12. Afjeh SA, Sabzehei MK, Karimi A, Shiva F, Shamshiri AR. Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome arch Iran Med 2012; 15: 567-571
13. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilatorassociated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003; 112: 1283-1289
14. Geffers C, Baerwolff S, Schwab F, Gastmeier P. Incidence of healthcare-associated infections in high-risk neonates: results from the German surveillance system for very-lowbirthweight infants. J Hosp Infect 2008; 68: 214-221
15. Yuan TM, Chen LH, Yu HM. Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients. J Perinat Med 2007; 35: 334-338
16. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States - National Nosocomial Infections Surveillance System. Pediatrics 1999; 103: e39
17. Gautam A, Ganu SS, Tegg OJ, et al. Ventilator-associated pneumonia in a tertiary paediatric intensive care unit: a 1-year prospective observational study. Crit Care Resusc 2012; 14: 283-289
18. Deng C, Li X, Zou Y, et al. Risk factors and pathogen profile of ventilator-associated pneumonia in a neonatal intensive care unit in China. Pediatr Int 2011; 53: 332-337
19. Tullu MS, Deshmukh CT, Baveja SM. Bacterial nosocomial pneumonia in paediatric intensive care unit. J Postgrad Med 2000; 46: 18-22
20. Stover BH, Shulman ST, Bratcher DF, et al. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units am J Infect Control 2001; 29: 152-157
21. Garland JS. Strategies to prevent ventilatorassociated pneumonia in neonates. Clin Perinatol 2010; 37: 629-643
22. Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR a prospective study of ventilator-associated pneumonia in children. Pediatrics 2009; 123: 1108-1115
23. Katayama Y, Minami H, Enomoto M, et al. Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates. J Perinatol 2010; 30: 270-274
24. Thomas W, Speer CP. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia - what is the evidence?. Neonatology 2008; 94: 150-159
25. Dancer SJ, Coyne M, Robertson C, et al antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 2006; 62: 200-206
26. Sachdev A, Chugh K, Sethi M, et al. Diagnosis of ventilator-associated pneumonia in children in resource-limited setting: a comparative study of bronchoscopic and nonbronchoscopic methods. Pediatr Crit Care Med 2010; 11: 258-266
27. Gauvin F, Lacroix J, Guertin MC, et al. Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated children am J Respir Crit Care Med 2002; 165: 1618-1623
28. Labenne M, Poyart C, Rambaud C, et al. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med 1999; 27: 2537-2543
29. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95
30. El-Ebiary M, Soler N, Monton C, Torres A. Markers of ventilator-associated pneumonia. Clin Intensive Care 1995; 6: 121-126
31. Palazzo SJ, Simpson T, Schnapp L. Biomarkers for ventilator-associated pneumonia: review of the literature. Heart Lung 2011; 40: 293-298
32. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011; 52(suppl 4): S346-S350
33. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011; 9: 107
34. Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34: 1434-1440
35. Oppert M, Reinicke A, Muller C, et al. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 2002; 53: 167-170
36. Duflo F, Debon R, Monneret G, et al alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia anesthesiology 2002; 96: 74-79
37. Zielinska-Borkowska U, Skirecki T, Zlotorowicz M, Czarnocka B. Procalcitonin in early onset ventilator-associated pneumonia. J Hosp Infect 2012; 81: 92-97
38. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 2010; 65: 201-207
39. Ramírez P, Ferrer M, Gimeno R, et al. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med 2009; 37: 1691-1695
40. Swanson JM, Mueller EW, Croce MA, et al. Changes in pulmonary cytokines during antibiotic therapy for ventilator-associated pneumonia. Surg Infect (Larchmt) 2010; 11: 161-167
41. Determann RM, Millo JL, Gibot S, et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005; 31: 1495-1500
42. Horonenko G, Hoyt JC, Robbins RA, et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007; 132: 58-63
43. Srinivasan R, Song Y, Wiener-Kronish J, Flori HR. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med 2011; 12: 21-27
44. Escobar J, Teramo K, Stefanovic V, et al amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies. Neonatology 2013; 103: 193-198
45. Harwood DT, Nimmo SL, Kettle AJ, Winterbourn CC, Ashby MT. Molecular structure and dynamic properties of a sulfonamide derivative of glutathione that is produced under conditions of oxidative stress by hypochlorous acid. Chem Res Toxicol 2008; 21: 1011-1016
46. Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitoninguided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 2010; 97: 165-174
47. Assumma M, Signore F, Pacifico L, et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem 2000; 46: 1583-1587
48. Cernada M, Badia N, Modesto V, et al. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis acta Paediatr 2012; 101: e203-e207
49. Harwood DT, Darlow BA, Cheah FC, et al. Biomarkers of neutrophil-mediated glutathione and protein oxidation in tracheal aspirates from preterm infants: association with bacterial infection. Pediatr Res 2011; 69: 28-33
50. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study - European Study Group. Infect Control Hosp Epidemiol 2000; 21: 260-263
51. Blot S, Rello J, Vogelaers D. What is new in the prevention of ventilator-associated pneumonia?. Curr Opin Pulm Med 2011; 17: 155-159
52. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009; 22: 224-239, table of contents
53. Fischer JE, Allen P, Fanconi S. Delay of extubation in neonates and children after cardiac surgery: impact of ventilator-associated pneumonia. Intensive Care Med 2000; 26: 942-949
54. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics 2002; 109: 758-764
55. Foglia E, Hollenbeak C, Fraser V, Elward A. Costs associated with nosocomial bloodstream infections and ventilator-associated pneumonia in pediatric intensive care unit patients (abstract 109). 16th Annu Meet Soc Healthcare Epidemiol, Chicago, 2006
56. Brilli RJ, Sparling KW, Lake MR, et al. The business case for preventing ventilator-associated pneumonia in pediatric intensive care unit patients. Jt Comm J Qual Patient Saf 2008; 34: 629-638
57. Nakwan N, Wannaro J, Thongmak T, et al. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 2011; 46: 60-66
58. Badr MA, Ali YF, Albanna EA, Beshir MR, Amr GE. Ventilator associated pneumonia in critically-ill neonates admitted to neonatal intensive care unit, Zagazig University Hospitals. Iran J Pediatr 2011; 21: 418-424
59. Foglia E, Meier MD, Elward A. Ventilatorassociated pneumonia in neonatal and pediatric intensive care unit patients. Clin Microbiol Rev 2007; 20: 409-425, table of contents
60. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53: 1-36
61. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth 2009; 103: 867-873
62. Machado MC, Cheng D, Tarquinio KM, Webster TJ. Nanotechnology: pediatric applications. Pediatr Res 2010; 67: 500-504
63. Cordero L, Sananes M, Ayers LW. Comparison of a closed (Trach Care MAC) with an open endotracheal suction system in small premature infants. J Perinatol 2000; 20: 151-156
64. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care arch Intern Med 1999; 159: 821-826
65. Won SP, Chou HC, Hsieh WS, et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004; 25: 742-746
66. Rogers E, Alderdice F, McCall E, Jenkins J, Craig S. Reducing nosocomial infections in neonatal intensive care. J Matern Fetal Neonatal Med 2010; 23: 1039-1046
67. Ng SP, Gomez JM, Lim SH, Ho NK. Reduction of nosocomial infection in a neonatal intensive care unit (NICU). Singapore Med J 1998; 39: 319-323
68. Yildizdas D, Yapicioglu H, Yilmaz HL. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care 2002; 17: 240-245.
69. Ruza F, Alvarado F, Herruzo R, et al. Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Eur J Epidemiol 1998; 14: 719-727
70. Barret JP, Jeschke MG, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001; 27: 439-445
71. Herruzo-Cabrera R, Garcia Gonzalez JI, Garcia-Magan P, del Rey-Calero J. Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization: a multivariant evaluation of infection reduction. Eur J Epidemiol 1994; 10: 573-580
72. Manzoni P, De Luca D, Stronati M, et al. Prevention of nosocomial infections in neonatal intensive care units am J Perinatol 2013; 30: 81-88
73. Gu WJ, Wei CY, Yin RX. Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and metaanalysis of randomized controlled trials. Chest 2012; 142: 859-868